March 12, 2017

PhilLAB Holdings CEO meeting with investors in US ahead of planned IPO

  • HOME
  • Blog
  • PhilLAB Holdings CEO meeting with investors in US ahead of planned IPO
  • SAN FRANCISCO – Tom Navasero, of CEO and president PhiLAB Holdings Corp. (DNA PM) is in the United States this week to meet global investors ahead of the firm’s planned public share offering later this month.

    PhilLAB Holdings CEO Tom Navasero. WEBSITE

    PhiLAB was established in 1958 and is a leading Philippine supplier of life science equipment. Navasero is sharing with global investors information about PhiLAB’s growth strategy, including its pioneering work in medical home test kits.

    PhiLAB is newly listed on the Philippines public exchange. Last year, Navasero purchased 67 percent of Alterra Capital (ALT PM); earlier in 2017, that company’s name changed to PhiLAB and its ticker to DNA PM. Now, as a publicly traded company, PhiLAB plans a public share offering of approximately $40-60 million.

    Read full story via Inquirer

    Recent Comments
    What do you think about this article?
    ★★ ★★★ ★★★★ ★★★★★

    *

    You might also like...
    Netflix Movies to Watch for the Month of September
    September 24, 2017
    DLSU Manila makes its way for ADLAW Cruiser
    September 24, 2017
    Medical Professionals in Manila: Dr. Roschelle Cedeño, General Pediatrics
    September 24, 2017
    Butamaru: Bringing the ramen craze to Ortigas
    September 22, 2017
    News Rundown: September 18 to 22, 2017
    September 22, 2017